Vaccine Safety Body Proposed To Remove FDA “Conflict Of Interest”
Executive Summary
A proposal to move postmarket vaccine safety monitoring to an independent board outside FDA and CDC will be considered by the National Vaccine Advisory Committee at its next meeting